Skip to content
My WebMD Sign In, Sign Up

Medical Reference Related to Prostate Cancer

  1. Prostate Cancer Prevention (PDQ®): Prevention - Health Professional Information [NCI] - Risk Factors for Prostate Cancer Development

    Age Prostate cancer incidence increases dramatically with increasing age. While a very unusual disease in men younger than 50 years,rates increase exponentially thereafter. The registration rate by age cohort in England and Wales increased from 8 per thousand population in men aged 50 to 56 years to 68 per thousand in men aged 60 to 64 years,260 per thousand in men aged 70 to 74 years,and ...

  2. Prostate Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Summary of Evidence

    Note: Separate PDQ summaries on Prevention of Prostate Cancer,Prostate Cancer Treatment,and Levels of Evidence for Cancer Screening and Prevention Studies are also available. Digital Rectal Examination and Prostate-Specific Antigen Benefits The evidence is insufficient to determine whether screening for prostate cancer with prostate-specific antigen (PSA) or digital rectal exam (DRE) reduces ...

  3. Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Complementary and alternative medicine - Patient Information [NCI] - nci_ncicdr0000719565-nci-header

    This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Prostate Cancer, Nutrition, and Dietary Supplements

  4. Prostate Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Stage IV Prostate Cancer Treatment

    OverviewStage IV prostate cancer is defined by the American Joint Committee on Cancer's TNM classification system:[1]T4, N0, M0, any prostate-specific antigen (PSA), any Gleason.Any T, N1, M0, any PSA, any Gleason.Any T, any N, M1, any PSA, any Gleason.Extraprostatic extension with microscopic bladder neck invasion (T4) is included with T3a.Treatment selection depends on the following factors:Age.Coexisting medical illnesses.Symptoms.The presence of distant metastases (most often bone) or regional lymph node involvement only.The most common symptoms originate from the urinary tract or from bone metastases. Palliation of symptoms from the urinary tract with transurethral resection of the prostate (TURP) or radiation therapy and palliation of symptoms from bone metastases with radiation therapy or hormonal therapy are an important part of the management of these patients. Bisphosphonates may also be used for the management of bone

  5. Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Complementary and alternative medicine - Patient Information [NCI] - Introduction

    Men in the United States get prostate cancer more than any other type of cancer except skin cancer. It is found mainly in older men. In the United States, about one out of five men will be diagnosed with prostate cancer. Most men diagnosed with prostate cancer do not die of it.Complementary and alternative medicine (CAM) is a form of treatment used in addition to (complementary) or instead of (alternative) standard treatments. CAM treatments generally are not considered standard medical approaches. Standard treatments go through a long and careful research process to prove they are safe and effective, but less is known about most types of CAM. CAM use among prostate cancer patients is reported to be common. CAM treatments used by prostate cancer patients include certain foods, dietary supplements, herbs, vitamins, and minerals. This PDQ CAM summary gives general information about using foods and dietary supplements to lower the risk of developing prostate cancer or for treating

  6. Prostate Cancer Screening (PDQ®): Screening - Patient Information [NCI] - nci_ncicdr0000258032-nci-header

    This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Prostate Cancer Screening

  7. Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Complementary and alternative medicine - Patient Information [NCI] - Questions and Answers About Pomegranate

    What is pomegranate?The pomegranate fruit (Punica granatum L.) is native to Asia and grown throughout the Mediterranean, Southeast Asia, East Indies, Africa, and the United States. Pomegranate has been used for medicinal purposes since ancient times. Different parts of the pomegranate fruit have bioactive compounds (chemicals found in small amounts that have actions in the body that may promote good health). These include:the peel, which makes up half the fruit and contains bioactive compounds such as phenolics, flavonoids, and ellagitannins (the main source of antioxidant activity);the seeds, which contain punicic acid, an omega-5 fatty acid; andthe aril (outer layer surrounding the seeds), which contains phenolics and flavonoids including anthocyanins, which give the pomegranate fruit and juice their red color. How is pomegranate administered or consumed? Pomegranate may be consumed in the diet or taken in dietary supplements. Have any preclinical (laboratory or animal) studies been

  8. Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Complementary and alternative medicine - Health Professional Information [NCI] - Zyflamend

    OverviewZyflamend is a dietary supplement that contains extracts of rosemary, turmeric, ginger, holy basil, green tea, hu zhang, Chinese goldthread, barberry, oregano, and Baikal skullcap.The individual components of Zyflamend have anti-inflammatory and possible anticarcinogenic properties.In various preclinical studies, Zyflamend has been shown to suppress the expression of certain genes involved in the inflammatory response and in cancer progression, such as cyclooxygenase 1(COX-1), COX-2, 5-lipoxygenase (5-LOX), and 12-LOX.In other preclinical studies, Zyflamend has demonstrated single-agent anticancer activity, and the capacity to be combined with hormonal and chemotherapy agents for improved cancer suppression.Results of a phase I study of Zyflamend suggest that use of this supplement is not associated with serious toxicity or adverse effects.General Information and HistoryZyflamend is a dietary supplement that contains extracts of rosemary, turmeric, ginger, holy

  9. Prostate Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Stage Information for Prostate Cancer

    Staging TestsMost men are diagnosed with prostate cancer at an early clinical stage and do not have detectable metastases. Therefore, they generally do not have to undergo staging tests, such as a bone scan, computed tomography (CT), or magnetic resonance imaging (MRI). However, staging studies are done if there is clinical suspicion of metastasis, such as bone pain; local tumor spread beyond the prostate capsule; or a substantial risk of metastasis (prostate-specific antigen [PSA] >20 ng/ml and Gleason score >7).[1]Tests used to determine stage include the following:Radionuclide bone scans.Serum PSA level.MRI.Pelvic lymph node dissection (PLND).Transrectal or transperineal biopsy.Transrectal ultrasound (TRUS).CT scans.Radionuclide bone scansA radionuclide bone scan is the most widely used test for metastasis to the bone, which is the most common site of distant

  10. Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Complementary and alternative medicine - Health Professional Information [NCI] - Soy

    OverviewThis section contains the following key information:Soy foods (e.g., soy milk, miso, tofu, and soy flour) contain phytochemicals that may have health benefits and, among these, soy isoflavones have been the focus of most of the research.Soy isoflavones are phytoestrogens. The major isoflavones in soybeans are genistein (the most abundant), daidzein, and glycitein.Genistein affects components of multiple growth and proliferation -related pathways in prostate cancer cells, including the COX-2 /prostaglandin, epidermal growth factor (EGF), and insulin-like growth factor (IGF) pathways.Some preclinical studies have indicated that the combined effect of multiple isoflavones may be greater than that of a single isoflavone.Some animal studies have demonstrated prostate cancer prevention effects with soy and genistein; however, other animal studies have yielded conflicting results regarding beneficial effects of genistein on prostate cancer metastasis.Epidemiologic studies have

Displaying 31 - 40 of 208 Articles << Prev Page 1 2 3 4 5 6 7 8 9 10 Next >>

Today on WebMD

Prostate Cancer Overview
SLIDESHOW
what is your cancer risk
HEALTH CHECK
 
woman speaking with doctor
VIDEO
Prostate Nerve Transplant
VIDEO
 
cancer fighting foods
SLIDESHOW
15 Cancer Symptoms Men Ignore
FEATURE
 
Prostate Enlarged
VIDEO
Picture Of The Prostate
ANATOMY
 
Prostate Cancer Quiz
QUIZ
screening tests for men
SLIDESHOW
 
Prostate Cancer Symptoms
VIDEO
Vitamin D
SLIDESHOW